<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">2983306R</journal-id>
<journal-id journal-id-type="pubmed-jr-id">3565</journal-id>
<journal-id journal-id-type="nlm-ta">Epilepsia</journal-id>
<journal-id journal-id-type="iso-abbrev">Epilepsia</journal-id>
<journal-title-group>
<journal-title>Epilepsia</journal-title>
</journal-title-group>
<issn pub-type="ppub">0013-9580</issn>
<issn pub-type="epub">1528-1167</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">29023667</article-id>
<article-id pub-id-type="pmc">5716871</article-id>
<article-id pub-id-type="doi">10.1111/epi.13923</article-id>
<article-id pub-id-type="manuscript">NIHMS908061</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Postnatal Reduction of Tuberous Sclerosis Complex-1 Expression in Astrocytes and Neurons Causes Seizures in an Age-Dependent Manner</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Zou</surname>
<given-names>Jia</given-names>
</name>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zhang</surname>
<given-names>Bo</given-names>
</name>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Gutmann</surname>
<given-names>David H</given-names>
</name>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wong</surname>
<given-names>Michael</given-names>
</name>
</contrib>
<aff id="A1">Department of Neurology and the Hope Center for Neurological Disorders, Washington University School of Medicine, St. Louis, MO, USA 63110</aff>
</contrib-group>
<author-notes>
<corresp id="FN1">Correspondence: Michael Wong, MD, PhD, Department of Neurology, Box 8111, Washington University School of Medicine, 660 South Euclid Avenue, St. Louis, MO 63110, Phone: 314-362-8713; Fax: 314-362-9462; <email>wong_m@wustl.edu</email></corresp>
<fn fn-type="COI-statement" id="FN2">
<p>
<bold>DISCLOSURES</bold>
</p>
<p>None of the authors has any conflict of interest to disclose. We confirm that we have read the Journalâ€™s position on issues involved in ethical publication and affirm that this report is consistent with those guidelines.</p>
</fn>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>22</day>
<month>9</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="epub">
<day>12</day>
<month>10</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="ppub">
<month>12</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>01</day>
<month>12</month>
<year>2018</year>
</pub-date>
<volume>58</volume>
<issue>12</issue>
<fpage>2053</fpage>
<lpage>2063</lpage>
<!--elocation-id from pubmed: 10.1111/epi.13923-->
<abstract>
<title>SUMMARY</title>
<sec id="S1">
<title>Objective</title>
<p id="P2">Epilepsy is one of the most prominent symptoms of the genetic disorder, tuberous sclerosis complex (TSC), and may be related to developmental defects resulting from impaired <italic>TSC1</italic> or <italic>TSC2</italic> gene function in astrocytes and neurons. Inactivation of the <italic>Tsc1</italic> gene driven by a glial-fibrillary acidic protein (GFAP) promoter during embryonic brain development leads to widespread pathological effects on astrocytes and neurons, culminating in severe, progressive epilepsy in mice (<italic>Tsc1</italic><sup>GFAP-Cre</sup> mice). However, the developmental timing and cellular specificity relevant to epileptogenesis in this model has not been well defined. The present study evaluates the effect of postnatal <italic>Tsc1</italic> gene inactivation on pathological features of astrocytes and neurons and development of epilepsy.</p>
</sec>
<sec id="S2">
<title>Methods</title>
<p id="P3">An inducible <italic>Tsc1</italic> knock-out mouse was created utilizing a tamoxifen-driven GFAP-CreER line (<italic>Tsc1</italic><sup>GFAP-CreER</sup> mice) with TSC1 reduction induced postnatally at 2 and 6 weeks of age, and compared to conventional <italic>Tsc1</italic><sup>GFAP-Cre</sup> mice with prenatal TSC1 reduction. Western blotting, immunohistochemistry, histology, and video-EEG assessed mTOR pathway activation, astrogliosis, neuronal organization, and spontaneous seizures, respectively.</p>
</sec>
<sec id="S3">
<title>Results</title>
<p id="P4"><italic>Tsc1</italic> gene inactivation at 2 weeks of age was sufficient to cause astrogliosis and mild epilepsy in <italic>Tsc1</italic><sup>GFAP-CreER</sup> mice, but the phenotype was much less severe than observed with prenatal <italic>Tsc1</italic> gene inactivation in <italic>Tsc1</italic><sup>GFAP-Cre</sup> mice. Both astrocytes and neurons were affected by prenatal and postnatal <italic>Tsc1</italic> gene activation to a degree similar to the severity of epilepsy, suggesting that both cellular types may contribute to epileptogenesis.</p>
</sec>
<sec id="S4">
<title>Significance</title>
<p id="P5">These findings support a model in which the developmental timing of TSC1 loss dictates the severity of neuronal and glial abnormalities and resulting epilepsy.</p>
</sec>
</abstract>
<kwd-group>
<kwd>epilepsy</kwd>
<kwd>seizure</kwd>
<kwd>tuberous sclerosis</kwd>
<kwd>rapamycin</kwd>
<kwd>astrocyte</kwd>
<kwd>neuron</kwd>
<kwd>mice</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>